Biomarker ID | 698 |
PMID | 21804560 |
Year | 2011 |
Biomarker | PCAT-1 |
Biomarker Basis | Expression Based |
Biomolecule | ncRNA |
Source | Tissue |
Subjects | Humans |
Regulation | Upregulated in a subset of metastatic and high-grade localized (Gleason score ≥7) cancers |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | NA |
Experiment | High grade tumor vs. low grade tumor/non-tumor |
Type of Biomarker | Prognostic |
Cohort | 102 prostate tissues and cell lines: 20 benign adjacent prostates (benign), 47 localized prostate cancers (PCA), 14 metastatic tumors and 21 prostate cell lines were selected for analysis. |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | NA |
Method Used | RNA-seq |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Validated on two independent patient cohorts |
Technical Name | PCAT1 |